经颈动脉血流反转支架置入术结果的更新系统评价与荟萃分析
该更新系统评价与荟萃分析纳入18项研究共2110例经颈动脉血流反转支架置入术,技术成功率98.25%,死亡率0.48%,大卒中0.71%、小卒中0.90%、短暂性脑缺血发作0.57%、心肌梗死0.57%。荟萃分析显示汇总技术成功率98.69%,汇总死亡率0.04%,任何神经并发症汇总率1.88。结论认为该技术成功率高、死亡率近乎为零且卒中与并发症发生率低。
要点
- 经颈动脉血流反转支架置入术技术成功率高,汇总死亡率仅0.04%。
- 大卒中、小卒中、TIA和MI的汇总发生率均较低。
- 心动过缓/低血压汇总发生率10.21%,需关注术中血流动力学变化。
核心结论
- 经颈动脉血流反转支架置入术与高技术成功率、近乎零死亡率及低的大卒中、小卒中、心肌梗死和并发症发生率相关。
研究设计与样本
- 更新系统评价与荟萃分析,检索PubMed/MEDLINE、Embase和Cochrane数据库,纳入18项报告经颈动脉血流反转支架置入术结局的研究,共2110例手术。
主要发现
- 粗率:技术成功98.25%,死亡率0.48%,大卒中0.71%,小卒中0.90%,短暂性脑缺血发作0.57%,心肌梗死0.57%,颅神经损伤0.28%,颈部血肿1.04%,颈动脉夹层0.76%,转行颈动脉内膜切除术1.09%。
- 荟萃分析汇总率:技术成功98.69%(95%CI 97.19-99.70),死亡率0.04%(95%CI 0.00-0.29),任何神经并发症1.88(95%CI 1.24-2.61)。
- 汇总率:大卒中0.12%(95%CI 0.00-0.46),小卒中0.15%(95%CI 0.00-0.50),短暂性脑缺血发作0.01%(95%CI 0.00-0.22),心肌梗死0.08%(95%CI 0.00-0.39)。
- 汇总率:心动过缓/低血压10.21%(95%CI 3.99-18.51),颈部血肿1.51%(95%CI 0.22-3.54),转行颈动脉内膜切除术0.74%(95%CI 0.05-1.95),颈动脉夹层0.47%(95%CI 0.00-1.38)。
临床怎么用
- 经颈动脉血流反转支架置入术可作为颈动脉支架置入的替代选择,围术期需监测血流动力学变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Transcervical carotid artery stenting (CAS) has emerged as an alternative to transfemoral CAS. An earlier systematic review from our group (n = 12 studies; 739 transcervical CAS procedures [489/739 with flow reversal]) demonstrated that transcervical CAS is a safe procedure associated with a low incidence of stroke and complications. Since then, new studies have been published adding nearly 1600 patients to the literature. We aimed to update our early systematic review and also to perform a meta-analysis to investigate outcomes specifically after transcervical CAS with flow reversal. METHODS: An electronic search of PubMed/MEDLINE, Embase, and the Cochrane databases was carried out to identify studies reporting outcomes after transcervical CAS with flow reversal. Crude event rates for outcomes of interest were estimated by simple pooling of data. A proportion meta-analysis was also performed to estimate pooled outcome rates. RESULTS: A total of 18 studies (n = 2110 transcervical CAS procedures with flow reversal) were identified. A high technical success (98.25%) and a low mortality rate (0.48%) were recorded. The crude rates of major stroke, minor stroke, transient ischemic attack, and myocardial infarction (MI) were 0.71%, 0.90%, 0.57%, and 0.57%, respectively; a cranial nerve injury occurred in 0.28% of the procedures. A neck hematoma was reported in 1.04% of the procedures, and a carotid artery dissection occurred in 0.76% of the interventions; in 1.09% of the cases, conversion to carotid endarterectomy was required. After a meta-analysis was undertaken, the pooled technical success rate was 98.69% (95% confidence interval [CI], 97.19-99.70). A pooled mortality rate of 0.04% (95% CI, 0.00-0.29) was recorded. The pooled rate of any type of neurologic complications was 1.88 (95% CI, 1.24-2.61), whereas the pooled rates of major stroke, minor stroke, and transient ischemic attack were 0.12% (95% CI, 0.00-0.46), 0.15% (95% CI, 0.00-0.50), and 0.01% (95% CI, 0.00-0.22), respectively. The pooled rate of bradycardia/hypotension was 10.21% (95% CI, 3.99-18.51), whereas the pooled rate of MI was 0.08% (95% CI, 0.00-0.39). A neck hematoma after transcervical CAS was recorded in 1.51% (95% CI, 0.22-3.54) of the procedures; in 0.74% (95% CI, 0.05-1.95) of the interventions, conversion to CEA was required. Finally, a carotid artery dissection during transcervical CAS occurred in 0.47% (95% CI, 0.00-1.38) of the procedures. CONCLUSIONS: This updated systematic review and meta-analysis demonstrated that transcervical CAS with flow reversal is associated with high technical success, almost zero mortality, and low rates of major stroke, minor stroke, MI, and complications.
引用
- Paraskevas KI, Antonopoulos CN, Kakisis JD, et al. An updated systematic review and meta-analysis of results of transcervical carotid artery stenting with flow reversal. J Vasc Surg. 2020. PMID: 32422272. doi:10.1016/j.jvs.2020.04.501
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。